-
June 18, 2013
As per Reuters, several pharmaceutical companies have shown an interest in acquiring ViroPharma given the company's ...
-
June 18, 2013
Incyte announced positive long-term data from two ongoing studies on Jakafi.
-
June 18, 2013
The study will evaluate Iclusig's efficacy and safety in patients who have failed at least one tyrosine kinase ...
-
June 18, 2013
MannKind completed a phase III study on its diabetes candidate Afrezza.
-
June 18, 2013
Perrigo has purchased Fera's eye-care portfolio.
-
June 18, 2013
Celgene presented positive results on apremilast from a phase II study.
-
June 17, 2013
Namenda XR is a once-daily extended-release version of the company's immediate release formulation of Namenda.
-
June 17, 2013
XOMA Corporation announced the initiation of a pilot study to evaluate the use of gevokizumab in acute inflammatory ...
-
June 17, 2013
The EC approved Revlimid for MDS.
-
June 14, 2013
Incyte and Eli Lilly announced positive results from a study on baricitinib.
-
June 13, 2013
The FDA's advisory panel will review Salix' supplemental new drug application for Relistor for opioid-induced ...
-
June 13, 2013
The FDA updated Incyte's sole marketed product Jakafi's label.
-
June 13, 2013
Bristol-Myers presented encouraging long-term data from a phase IIIb study on Orencia.
-
June 12, 2013
With the markets continuing to move in an upwards manner, finding bargain is becoming harder and harder to do. In an ...
-
June 10, 2013
Elan's Board of Directors again rejected Royalty Pharma's offer to acquire all its shares.
-
June 10, 2013
Hyperion Therapeutics, Inc. acquired global rights to Buphenyl tablets and powder from Ucyclyd Pharma Inc., a ...
-
June 10, 2013
Gentium S.p.A. announced that it is seeking a re-examination of the negative opinion issued on defibrotide by the ...
-
June 10, 2013
AstraZeneca entered into an agreement with Hanmi Pharmaceutical to resolve patent issues related to Nexium
-
June 10, 2013
Alexion announced that encouraging data on Soliris has been published for treating aHUS patients.
-
June 10, 2013
As we enter the bumpy summer months, large-cap US domestic stocks and health-care names are on Louis Navellier's ...
